Analysis of cerebrospinal fluid cell populations with monoclonal antibodies
Language English Country United States Media print
Document type Evaluation Study, Journal Article
PubMed
18298052
DOI
10.1007/bf02932115
Knihovny.cz E-resources
- MeSH
- Antigens, CD cerebrospinal fluid immunology MeSH
- Encephalitis, Viral immunology MeSH
- Humans MeSH
- Lyme Neuroborreliosis immunology MeSH
- Meningitis, Viral immunology MeSH
- Antibodies, Monoclonal immunology MeSH
- Cerebrospinal Fluid cytology immunology MeSH
- Central Nervous System Diseases cerebrospinal fluid diagnosis immunology MeSH
- Lymphocyte Subsets cytology immunology MeSH
- Flow Cytometry methods MeSH
- Multiple Sclerosis immunology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Evaluation Study MeSH
- Names of Substances
- Antigens, CD MeSH
- Antibodies, Monoclonal MeSH
Sixty-five samples of cerebrospinal fluid (CSF) were evaluated using an automated cytoflow method with the CD-Sapphire hematology analyzer in order to investigate possible relationships between cell population patterns and diagnostic groups and better understand the biology of neurological disease. A basic panel of CD markers, including CD3/4/8/19/138/HLA-DR, was used to analyze CSF samples from clinical and laboratory confirmed cases of multiple sclerosis, neuroborreliosis, viral and bacterial neuroinfective diseases, malignant infiltrations of meninges and scavenger macrophagic reactions of the central nervous system. The principles of immune response and the contribution of cytological 'disease-related patterns' for these nosological entities are described. The distinct patterns of lymphocyte subpopulations in neuroborreliosis appear to be characteristic and could possibly serve as diagnostic indicators. Further verification and research will be necessary to clarify the significance and nature of CD4+ CD8+ positive subset in cerebrospinal fluid.
See more in PubMed
J Neuroimmunol. 2006 Nov;180(1-2):33-9 PubMed
Brain. 2005 Jul;128(Pt 7):1667-76 PubMed
Folia Microbiol (Praha). 2006;51(6):599-603 PubMed
Folia Microbiol (Praha). 2003;48(6):839-47 PubMed
Ann Neurol. 2004 Jul;56(1):97-107 PubMed
J Neurol. 1980;224(2):77-87 PubMed
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8389-94 PubMed
J Infect Dis. 2003 Mar 15;187(6):963-73 PubMed
Folia Microbiol (Praha). 2003;48(6):849-55 PubMed
J Neurol Sci. 2005 Jan 15;228(1):75-85 PubMed
Folia Microbiol (Praha). 2006;51(5):485-91 PubMed
Acta Neurol Scand. 2002 Nov;106(5):302-8 PubMed
Proc Natl Acad Sci U S A. 2004 Jul 27;101(30):11064-9 PubMed
Pathol Res Pract. 2003;199(10):667-75 PubMed
Neoplasma. 2004;51(5):345-51 PubMed
Blood. 1993 Sep 1;82(5):1546-52 PubMed
Adv Clin Chem. 2001;36:1-62 PubMed
Clin Immunol. 2002 Jun;103(3 Pt 1):309-16 PubMed
Recommendations for cerebrospinal fluid analysis
Rapid flow cytometric method for viability determination of solventogenic clostridia